Mangalam Drugs gearing up for Covid-19 drug
Shares of Mangalam Drugs and Organics, engaged in the business of manufacturing of various active pharmaceutical ingredients (APIs) for anti-malaria,24-03-2020
24-03-2020
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Company Update On Active Pharmaceutical Ingredients (Apis) - Chloroquine Phosphate And Hydroxychloroquine Sulphate.
Company Update on Active Pharmaceutical Ingredients (APIs) - Chloroquine Phosphate and Hydroxychloroquine Sulphate.23-03-2020
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 25, 2020 for Raj Exports Pvt Ltd25-02-2020
Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 25, 2020 for Shri JB Pharma LLP25-02-2020
Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 24, 2020 for Shree Kishoriju Trading and Investment Pvt Ltd24-02-2020
Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 24, 2020 for Shree Rasbihari Trading and Investment Pvt Ltd24-02-2020
Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement regarding publication of Un-Audited Financial Results for the quarter and nine months ended December 31, 2019.27-01-2020
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2019.
In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we are enclosing herewith Un-audited Financial Results for the quarter and nine months ended December 31, 2019 along with Limited Review Report of the said period in the prescribed form which have been taken on record and approved by the Board of Directors of the Company in its meeting held today i.e. Friday, January 24, 2020 at Mumbai. Kindly note that meeting of Board of Directors commenced at 2:30 P.M. and concluded at 3:40 P.M. Further please note that the Company has made necessary arrangement to publish the same in newspapers as required under the Listing Regulations.24-01-2020
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Outcome Of The Board Meeting Held On Friday, January 24, 2020.
In terms of Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we have to inform you that the Board of Directors of the Company, in their meeting held today i.e. Friday, January 24, 2020 has inter-alia approved the Un-Audited Financial Results for the quarter and nine months ended December 31, 2019 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations. The meeting of Board of Directors commenced at 2:30 P.M. and concluded at 3:40 P.M.24-01-2020
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement regarding Board Meeting Intimation.21-01-2020